AROC3-1001 is a phase 1/2, placebo controlled, dose-escalating study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of ARO-C3
Through this acquisition, Ayu Health will add 1000 beds to provide localised primary and tertiary medical care for citizens of Jaipur
Parkinson's disease treatment is the first and only carbidopa/levodopa (CD/LD) tablet designed to be divided for precise dosing
Monitoring results demonstrated a good safety profile of the combination. No serious adverse events related to vaccination were registered
_256_384.jpg){kind=logo}
Shilpa Biologicals has tie-ups with Zydus to supply ZyCoV-D vaccine drug substance and Dr Reddy’s to make Sputnik V from its facility in Dharwad
EBITDA from Continuing Operations at Rs. 582 crore recorded a growth of 31 %.
The partnership includes multiple collaboration areas and is an important milestone for bringing cost-competitive biobased products to the market, with applications in the pharmaceutical, agricultural, cosmetics and personal care, and automotive industries
IOL Chemicals and Pharmaceuticals has reported standalone financial results for the period ended December 31, 2021
The audit is a PAI for two of its product applications filed from this facility
Intranasal vaccines are easier to administer in mass immunisation campaigns and help reduce or stop transmission
Subscribe To Our Newsletter & Stay Updated
